Cargando…
Transgene Optimization, Immunogenicity and In Vitro Efficacy of Viral Vectored Vaccines Expressing Two Alleles of Plasmodium falciparum AMA1
BACKGROUND: Apical membrane antigen 1 (AMA1) is a leading candidate vaccine antigen against blood-stage malaria, although to date numerous clinical trials using mainly protein-in-adjuvant vaccines have shown limited success. Here we describe the pre-clinical development and optimization of recombina...
Autores principales: | Biswas, Sumi, Dicks, Matthew D. J., Long, Carole A., Remarque, Edmond J., Siani, Loredana, Colloca, Stefano, Cottingham, Matthew G., Holder, Anthony A., Gilbert, Sarah C., Hill, Adrian V. S., Draper, Simon J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3116848/ https://www.ncbi.nlm.nih.gov/pubmed/21698193 http://dx.doi.org/10.1371/journal.pone.0020977 |
Ejemplares similares
-
Identification of adjuvants for clinical trials performed with Plasmodium falciparum AMA1 in rabbits
por: Younis, Sumera, et al.
Publicado: (2019) -
Phase Ia Clinical Evaluation of the Safety and Immunogenicity of the Plasmodium falciparum Blood-Stage Antigen AMA1 in ChAd63 and MVA Vaccine Vectors
por: Sheehy, Susanne H., et al.
Publicado: (2012) -
Humoral Immune Response to Mixed PfAMA1 Alleles; Multivalent PfAMA1 Vaccines Induce Broad Specificity
por: Kusi, Kwadwo A., et al.
Publicado: (2009) -
Generation of Humoral Immune Responses to Multi-Allele PfAMA1 Vaccines; Effect of Adjuvant and Number of Component Alleles on the Breadth of Response
por: Kusi, Kwadwo A., et al.
Publicado: (2010) -
Safety and Immunogenicity of a Recombinant Plasmodium falciparum AMA1 Malaria Vaccine Adjuvanted with Alhydrogel™, Montanide ISA 720 or AS02
por: Roestenberg, Meta, et al.
Publicado: (2008)